IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing treatments for cannabinoid overdose and substance addiction.
Industry: Health Care
Latest Trade: $3.01 0.00 (0.0%)
First Day Return: +1.4%
Return from IPO: -57.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/01/2021 |
Offer Price | $7.00 |
Price Range $6.00 - $8.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $21 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/06/2021 |
Offer Price | $7.00 |
Price Range $6.00 - $8.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $21 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
The Benchmark Company |
Company Data | |
---|---|
Headquarters | Lakeway, TX, United States |
Founded | 2020 |
Employees | 2 |
Website www.anebulo.com |